- Report
- November 2026
- 378 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 183 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- May 2026
- 100 Pages
Global
From €2493EUR$2,699USD£2,085GBP
- Report
- February 2026
- 192 Pages
Global
From €4614EUR$4,995USD£3,859GBP
- Report
- December 2025
Global
From €6927EUR$7,500USD£5,794GBP
- Report
- April 2026
- 115 Pages
South Africa
From €2023EUR$2,190USD£1,692GBP
- Report
- June 2023
- 180 Pages
Global
From €5496EUR$5,950USD£4,597GBP
- Report
- August 2025
- 188 Pages
Global
From €4156EUR$4,500USD£3,477GBP
- Report
- August 2024
- 80 Pages
Japan
From €3233EUR$3,500USD£2,704GBP
- Report
- July 2024
- 100 Pages
Global
From €3464EUR$3,750USD£2,897GBP
- Report
- January 2022
- 60 Pages
Global
From €3648EUR$3,950USD£3,052GBP
- Report
- May 2024
- 128 Pages
Global
From €3694EUR$3,999USD£3,089GBP
- Report
- May 2024
- 128 Pages
Global
From €3694EUR$3,999USD£3,089GBP
- Report
- June 2025
- 400 Pages
Global
From €4571EUR$4,949USD£3,823GBP
- Report
- May 2024
- 160 Pages
Global
From €4590EUR$4,969USD£3,839GBP
- Report
- February 2024
- 180 Pages
Global
From €4590EUR$4,969USD£3,839GBP
- Report
- October 2025
- 160 Pages
Global
From €2919EUR$3,160USD£2,441GBP
€3648EUR$3,950USD£3,052GBP
- Report
- October 2025
- 160 Pages
Global
From €2919EUR$3,160USD£2,441GBP
€3648EUR$3,950USD£3,052GBP
- Report
- April 2025
- 126 Pages
Asia Pacific
From €3187EUR$3,450USD£2,665GBP
- Report
- June 2023
- 347 Pages
Global
From €3325EUR$3,600USD£2,781GBP

Thrombosis is a medical condition in which a blood clot forms in a blood vessel, obstructing the flow of blood. It is a major concern in hematology, as it can lead to serious complications such as stroke, heart attack, and pulmonary embolism. Treatment of thrombosis typically involves anticoagulants, which are drugs that reduce the ability of the blood to clot. In some cases, thrombolytic drugs may be used to dissolve the clot.
The thrombosis market is a rapidly growing segment of the hematology market, driven by the increasing prevalence of thrombosis and the development of new treatments. The market is expected to benefit from the introduction of novel drugs and therapies, as well as the increasing demand for better diagnosis and treatment of thrombosis.
Some of the major companies in the thrombosis market include Bayer AG, Pfizer Inc., Sanofi, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more